DAIC

FEBRUARY 12, 2024

5,6 “We are very proud that our DX technology provides the only lead available on the market offering both ventricular pacing/defibrillation and atrial monitoring,” said Ryan Walters, BIOTRONIK US President. Journal of Cardiovascular Electrophysiology, Volume 30, Issue 10, October 2019, Pages 1994–2001. 2023;12:e029126.

Technology 64

Technology Atrial Fibrillation Defibrillator Sudden Cardiac Death 64

Journal of Cardiovascular Electrophysiology

JANUARY 29, 2024

Abstract The subcutaneous implantable cardioverter defibrillator (S-ICD) was developed as an alternative to the traditional transvenous implantable cardioverter defibrillator (TV-ICD), aiming to provide easier implantation, simplified detection algorithm of malignant ventricular arrhythmias and prevention from placing components in the cardiovascular (..)

Defibrillator 40

Defibrillator Electrocardiogram Technology Arrhythmia 40

Journal of Cardiovascular Electrophysiology

FEBRUARY 7, 2024

Progressive decline across periods in mortality rates among patients with implantable cardioverter-defibrillator (ICD). Abstract Introduction Despite advancements in implantable cardioverter-defibrillator (ICD) technology, sudden cardiac death (SCD) remains a persistent public health concern.

Defibrillator 40

Defibrillator Sudden Cardiac Death Tachycardia Public Health 40

All About Cardiovascular System and Disorders

APRIL 17, 2024

Ventricular tachycardia is a potentially life threatening cardiac arrhythmia. Chronic recurrent monomorphic VT like fascicular tachycardia and right ventricular outflow tract tachycardia are also amenable to electrophysiological mapping and ablation. If the rate is very fast, hemodynamic deterioration can occur rapidly.

Tachycardia 52

Tachycardia Defibrillator Congenital Ischemia 52

Journal of Cardiovascular Electrophysiology

DECEMBER 16, 2024

ABSTRACT Aim To evaluate the predictive value of preoperative echocardiographic parameters for occurrence of VAs in patients with preexisting ICD undergoing LVAD implantation. Methods and Results All consecutive patients ( n =264) with previous ICD who underwent LVAD surgery between May 2011 and December 2019 at our institution were included.

Defibrillator 40

Defibrillator Arrhythmia Tricuspid Bicuspid/Mitral 40

Circulation: Arrhythmia and Electrophysiology

JANUARY 29, 2024

Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:There is no specific treatment for sudden cardiac arrest (SCA) manifesting as pulseless electric activity (PEA) and survival rates are low; unlike ventricular fibrillation (VF), which is treatable by defibrillation.

Cardiac Arrest 40

Cardiac Arrest Chest Pain Coronary Artery Disease Defibrillator 40

Journal of Cardiovascular Electrophysiology

FEBRUARY 21, 2024

Abstract Introduction Wearable cardioverter defibrillator (WCD) is utilized in patients with assumed but not yet confirmed risk for sudden cardiac death (SCD). However, the rate of WCD-detected ventricular or atrial arrhythmia events in this specific high-risk cohort is not well understood. events per 100 patient-years vs. 74.8

Atrial Fibrillation 40

Atrial Fibrillation Sudden Cardiac Death Arrhythmia Outcomes 40

Circulation: Arrhythmia and Electrophysiology

FEBRUARY 20, 2025

Circulation: Arrhythmia and Electrophysiology, Ahead of Print. The primary composite outcome included sustained ventricular arrhythmia, appropriate implantable cardioverter defibrillator (ICD) therapy, aborted cardiac arrest, or sudden cardiac death.RESULTS:A total of 100 primary prevention children were included (7.15.6

Arrhythmia 40

Arrhythmia Cardiomyopathy Pediatrics Sudden Cardiac Death 40

Dr. Smith's ECG Blog

APRIL 8, 2016

At cath, he immediately had incessant Torsades de Pointes requiring defibrillation 7 times and requiring placement of a transvenous pacer for overdrive pacing at a rate of 80. IV administration of potassium is indicated when arrhythmias are present or hypokalemia is severe (potassium level of less than 2.5 Mean baseline [K] p was 2.9

STEMI 52

STEMI Myocardial Infarction Cardiac Arrest Arrhythmia 52

Dr. Smith's ECG Blog

JANUARY 30, 2019

Prior to Mizusawa's study, it was thought that the incidence of syncope, arrhythmia, or SCD in this cohort was low [7]. In light of the risk of arrhythmia events observed in the Mizusawa trial, a formal EP study might be reasonable to obtain in those with fever induced asymptomatic Brugada ECG changes to help risk stratify these patients.

Heart Rhythm 52

Heart Rhythm Sudden Cardiac Death Arrhythmia STEMI 52

Dr. Smith's ECG Blog

DECEMBER 5, 2019

A score including ECG pattern, early familial SCD antecedents, inducible electrophysiological study, presentation as syncope or as aborted SCD and SND had a predictive performance of 0.82. Conclusion of this paper: Fever is a great risk factor for arrhythmia events in Brugada Syndrome patients. and proband status (HR 2.1).

Sudden Cardiac Death 52

Sudden Cardiac Death Heart Rhythm Article Tachycardia 52

Dr. Smith's ECG Blog

DECEMBER 20, 2024

This is the shock coil and identifies this device as a defibrillator. CRT-D is cardiac resynchronization therapy with defibrillation capability, like the CXR above. CRT-P is cardiac resynchronization therapy with pacing only, without the ability to defibrillate. Specifically, it overlies a thicker radiopaque segment.

Chest Pain 103

Chest Pain Tachycardia Pacemaker Defibrillator 103